Cyclerion Therapeutics Inc
Biotechnology
Healthcare
CYCN
3.07 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.83
52 week high
6.35
high
3.17
52 week low
0.00
low
2.70
growth
3.07 %
previous Close
3.04
P/E ratio
market cap
8.55 M
div yield
0
usd
Jun 2025
qoq
revenue
93.00 K
14.81 %
net incoming
-324.00 K
77.33 %
eps
0.00 %
81.13 %
eps surprise
0.00 %
net profit margin
-348.39 %
1415.00 %
operating incoming
-1.67 M
-14.76 %
net change in cash
-633.00 K
-255.53 %
cash on hand
3.01 M
-17.39 %
cost of revenue
0.00 %
top top